Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Vaccine Lot Production (Research, Investigational, and Commercial)

Active

Federal

Response Deadline10/30/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the production of influenza vaccine antigens and vaccines across research, investigational, and commercial bulk scales to support prime contractors on BARDA pandemic preparedness projects. The work is performed within cGMP compliant facilities to ensure all investigational and commercial lots meet strict regulatory alignment and quality standards. Managed by the Department of Health and Human Services under the Barda agency, the contract focuses on delivering bulk vaccine lots across three distinct production scales. The opportunity is categorized under NAICS code 325412, with a response deadline set for October 30, 2026, and performance based in Washington.

General Info

cGMP production of influenza vaccine antigens for BARDA pandemic preparedness in Washington.

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda DcmaView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Washington, DC, 20024, USA

Set-Aside

NONE

Documents

This scope was carved out of 75A50126R00001_RFP_NPIVS_27.

The full solicitation package (19 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 17

subcontract

Response DeadlineOct 30

Submission deadline

Response Deadline

10/30/2026, 09:00:00 PM UTCin about 2 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Produces influenza vaccine antigens and vaccines at research, investigational, and commercial bulk scales for prime contractors on BARDA pandemic preparedness projects. Operates within cGMP compliant facilities for investigational and commercial lots to ensure regulatory alignment. Delivers bulk vaccine lots across three production scales.

Similar Contracts

Same NAICS industry code

BENZONATATE CAPSULES

Solicitation # SPE2DP-26-T-4957

This contract is for the procurement of Benzonatate Capsules, USP, 100 mg, provided in bottles of 100 units. The items must be stored at a controlled room temperature between 20 and 25 degrees Celsius and protected from light, moisture, and humidity. The order consists of two bottles under NSN 6505006601798, with a non-extendable shelf life of 36 months. The agreement specifies a delivery timeframe of 20 days after receipt of the order, with FOB destination for both inspection and acceptance. Compliance with FDA regulations, DLA packaging requirements, and Medical Marking Standard No. 1 is mandatory. The solicitation is managed by the Department of Defense Medical Supply Chain Pharmacy FSA under contract number SPE2DP-26-T-4957.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

FAMOTIDINE TABLETS

Solicitation # SPE2DP-26-T-4955

This contract, identified as SPE2DP-26-T-4955, is for the procurement of Famotidine Tablets, 20 mg, in unit dose packages of 100 tablets. The requirement includes two line items with a total quantity of 15 packages, delivered FOB destination to locations in Baumholder, Germany. The drug is FDA regulated and must adhere to a non-extendable shelf-life requirement of 30 months. Compliance with DLA packaging and marking standards is mandatory, specifically Medical Marking Standard No. 1 and RP001 for palletization. All items must be secured in sealed unit containers and commercial exterior shipping containers to prevent damage. Delivery is required within 10 days, with required delivery dates set for September 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

ISONIAZID TABLETS

Solicitation # SPE2DP-26-T-4951

This contract, identified as SPE2DP-26-T-4951, is for the procurement of Isoniazid Tablets USP, 300 mg, supplied in bottles of 100. The drug is FDA regulated and requires storage at medical controlled room temperature. The agreement specifies a non-extendable shelf life of 36 months and mandates compliance with the latest Medical Marking Standard No. 1 and DLA packaging requirements. Additionally, the contract prohibits the intentional addition of mercury or mercury-containing compounds to the supplies. The order consists of three line items totaling nine bottles, distributed across three different vessels: the USS Kidd, USS Roosevelt, and USS Canberra. Delivery is required within 20 days, with required delivery dates set for September 2026. Shipping is designated as FOB Destination, and the contractor must adhere to specific marking and labeling standards, including MIL-STD-129 and ASTM D3951 for non-hazardous materials.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-26-T-4856

This contract is for the procurement of Povidone-Iodine Cleansing Solution, USP 7.5%, supplied in one-gallon bottles. The product is regulated by the FDA and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. A critical requirement is the shelf life, which is 36 months total, with at least 31 months remaining at the time of delivery to the first government activity. The agreement includes three separate line items totaling 13 bottles to be delivered to the USNS Billy Frank Jr, USS Ashland, and USS Springfield. Delivery is required within five days, and the shipping terms are FOB Destination. Suppliers must comply with DLA packaging and marking standards, including Medical Marking Standard No. 1, and must provide Safety Data Sheets and hazardous communication labels in accordance with OSHA and Federal Standard No. 313-E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-26-T-4794

Solicitation SPE2DP-26-T-4794 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of activated suspension charcoal, identified by NSN 6505-01-282-8880. The requirement consists of three line items totaling 57 bottles, with each bottle containing 240 ml and 50 grams of material. Delivery is required within 20 days after receipt of order, with a target delivery date of September 2, 2026. Shipments are designated as FOB Destination, with delivery locations including the USS KIDD DDG 100, Fort Bragg NC, and an FPO address in AP. The product must have a shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Storage must be maintained at 20 to 25 degrees Celsius. Packaging must comply with DLA Packaging Requirements for Procurement RP001 and ASTM D3951, unless the material is deemed hazardous per FED-STD-313, in which case TQ requirement IP025 applies. Labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. All materials must be marked according to Medical Marking Standard No. 1. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The procurement is subject to various federal regulations, including the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity assessment requirements. Quotations are due by September 8, 2026, and must be submitted to the DLA Troop Support office in Philadelphia, Pennsylvania.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-415G

This contract is for the procurement of medical test strips and color charts used to analyze bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobiligen in urine. The items are issued in bottles containing 100 strips each, with a total quantity of two bottles requested under solicitation SPE2DS-26-T-415G. Delivery is required within 20 days after receipt of the order. The supplies must adhere to strict quality and packaging standards, including Medical Marking Standard No. 1 and DLA packaging requirements. A critical shelf-life requirement of 18 months applies, with a mandate that no more than two months may have elapsed from the date of manufacture to the date of delivery. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 7 hours ago

DEADLINE

LEVONORGESTREL AND ETH

Solicitation # SPE2DP-26-T-4956

This contract is for the procurement of Levonorgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription medication. Each unit of issue consists of one package containing 168 tablets, organized into six cycles of 28 tablets each. Each cycle follows a specific sequence of varying dosages of Levonorgestrel and Ethinyl Estradiol, concluding with seven tablets of inert ingredients. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius. The tablets have a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Packaging and marking must strictly adhere to Medical Marking Standard No. 1A and DLA packaging requirements to ensure the protection of contents during transit. Delivery is set for 20 days after the order, with the inspection and acceptance point designated as the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

NORGESTREL AND ETHINYL

Solicitation # SPE2DP-26-T-4961

This contract is for the procurement of Norgestrel and Ethinyl Estradiol tablets, an FDA-regulated prescription drug for oral administration. Each unit of issue consists of a package containing six blister card dispensers, with each card holding 21 active tablets (0.3 mg Norgestrel and 0.03 mg Ethinyl Estradiol) and 7 inactive tablets, totaling 168 tablets per package. The product has a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Storage must be maintained at controlled room temperature between 20 and 25 degrees Celsius. The agreement specifies strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements to ensure the protection of contents from damage during transit. It explicitly prohibits the intentional addition of mercury or mercury-containing compounds. Delivery is set for destination, with a required delivery date of September 10, 2026, and a delivery window of 20 days. The contract is managed by the Department of Defense Medical Supply Chain Pharmacy FSA, with shipping destined for Prince Sultan Air Base in Saudi Arabia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

DEXTROSE ORAL GEL

Solicitation # SPE2DP-26-T-4966

This contract is for the procurement of Dextrose Oral Gel, provided in 15 gram squeeze tubes with twist-off tips and packaged in sets of three. The product is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. The procurement includes two separate line items for a total of five packages, with delivery required within 20 days after the order. Shipping is designated as FOB Destination to the USNS Impeccable and USS California. All items must be marked according to Medical Marking Standard No. 1 and packaged in suitable sealed containers to prevent damage. The contract mandates compliance with DLA packaging requirements and specifies that shipments must be made via traceable means, explicitly prohibiting the use of parcel post.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-26-T-411U

This contract is for the procurement of DPD total chlorine test reagent, specifically provided as 100 powder pillows designed for a 10 ml sample size. The order consists of one package containing 100 units, with a required delivery timeframe of 20 days after the order is placed. The item is identified by NSN 6550-01-460-7597 and falls under the medical supply chain of the Department of Defense. The reagent must adhere to a strict shelf life of 60 months, with a requirement that no more than 8 months have passed from the date of manufacture to the date of delivery. Packaging must meet commercial standards and be sealed to prevent damage, with all labeling and marking complying with Medical Marking Standard No. 1. Additionally, the supplier must follow DLA packaging requirements and ensure all labels include the contract number, lot number, and relevant manufacture and expiration dates.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 7 hours ago

DEADLINE

POVIDONE-IODINE TOPICA

Solicitation # SPE2DP-26-T-4848

Contract SPE2DP-26-T-4848 is for the procurement of Povidone-Iodine Topical Solution, USP, under NSN 6505010672812. The requirement consists of multiple line items totaling 98 bottles, each with a 4 fluid ounce capacity. The product must have a total shelf life of 36 months, with at least 31 months remaining at the time of delivery to the first government activity. Delivery is specified as FOB Destination to the Medical Company Medical Logistics at Fort Bragg, North Carolina, with a required delivery date of September 3, 2026. The contract mandates strict adherence to FDA regulations and DLA technical and quality requirements. Packaging must be commercial and sealed to prevent damage, with labeling and marking following Medical Marking Standard 1 and MIL-STD-129. Labels must include the NSN, manufacturer and CAGE code, manufacture and expiration dates, and the contract or lot number. All shipments must be sent via traceable means, and the contractor must comply with specific palletization and hazardous material packaging standards where applicable.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

POVIDONE-IODINE TOP

Solicitation # SPE2DP-26-T-4958

This contract is for the procurement of Povidone-Iodine Topical Solution, USP, 10 percent, in 1/2 fl oz bottles. The item is supplied in packages of 50 bottles per unit of issue. It is a critical application item regulated by the FDA, with a total shelf life of 36 months, requiring at least 31 months of shelf life to remain upon delivery to the first government activity. The agreement specifies strict adherence to DLA packaging and medical marking standards, specifically Medical Marking Standard No. 1 and MIL-STD-129. Delivery is set as FOB Destination to San Antonio, Texas, with a required delivery timeframe of 5 days after order. The contract includes specific requirements for commercial packaging and the removal of government identification from non-accepted supplies.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

cGMP Vaccine Seed Lot ManufacturingThis subcontract for cGMP Vaccine Seed Lot Manufacturing involves the production of yield-optimized Master Virus Seed, Working Virus Seed lots, or bacterial cell banks to support BARDA pandemic preparedness projects. The work is performed for prime contractors using qualified CVV reference strains within cGMP certified facilities that align with FDA-licensed vaccines or submitted BLAs. All seeds are characterized according to qualified internal standard operating procedures to ensure the delivery of certified lots. Managed by the Department of Health and Human Services under Barda, the contract falls under NAICS code 325412. The performance location is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 2 months

Candidate Vaccine Virus (CVV) Development & CharacterizationThis subcontract, titled Candidate Vaccine Virus Development and Characterization, supports BARDA pandemic preparedness projects by preparing and characterizing both non-GLP and GLP influenza Candidate Vaccine Viruses. The scope of work includes performing HA/NA sequencing, genetic stability testing, ferret pathogenicity, two-way antigenicity, HA titer, sterility, and exclusivity. Additionally, the contractor is responsible for conducting plaque assays and chicken embryo lethality for HPAI strains within a BSL-2 environment, culminating in the delivery of final reports and Certificates of Analysis or Compliance. Managed by the Department of Health and Human Services under the Barda - Aspr agency, the project is categorized under NAICS code 541714. The performance location is based in Washington, DC. The solicitation was posted on August 17, 2026, with a response deadline set for October 30, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 2 months

Specialized Material Supply (Vials, Stoppers, Seals)This subcontract for Specialized Material Supply focuses on providing critical medical-grade components, including vials, stoppers, seals, and crimps, to support prime contractors on BARDA pandemic preparedness projects. The scope of work requires the delivery of physical inventory and the provision of comprehensive supply chain narratives that detail the country of origin and tariff exposure for all containment and closure materials. Managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, the contract is categorized under NAICS code 326199. The place of performance is located in Washington, DC, with a response deadline set for October 30, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

in about 2 months

Labeling, Packaging, and Cold Chain StorageThis subcontract, managed by the Department of Health and Human Services under BARDA, focuses on providing essential labeling, packaging, and specialized stability storage for bulk and final vaccine products. The scope of work involves supporting prime contractors on pandemic preparedness projects by managing cold chain logistics and stability monitoring for commercial scale bulk antigens, final containers, and bulk adjuvants. The contractor is responsible for the delivery of packaged products and the provision of detailed stability reports. This opportunity is categorized under NAICS code 493110 and is based in Washington, DC. The response deadline for this requirement is October 30, 2026.

General Warehousing and Storage

POSTED

DEADLINE

in about 2 months

Formulation, Filling, and Finishing ServicesThis subcontract for Formulation, Filling, and Finishing Services supports BARDA pandemic preparedness projects by providing final formulation and filling of antigens, adjuvants, or co-formulated products into final containers. The work is performed under cGMP compliant processes within sterile filling environments to ensure the delivery of high-quality filled vials and containers for prime contractors. The opportunity is managed by the Department of Health and Human Services under the Barda - Aspr / Daappo / Barda Dcma agency and is categorized under NAICS code 325412. The project is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 2 months

cGMP Adjuvant ManufacturingThis subcontract, titled cGMP Adjuvant Manufacturing, involves the production of clinical or commercial scale bulk lots of vaccine adjuvants to support BARDA pandemic preparedness projects. The primary objective is to manufacture these adjuvants within cGMP certified facilities to enhance the efficacy of influenza vaccines as part of United States Government efforts. The contract is managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, with the place of performance located in Washington. The solicitation was posted on August 17, 2026, with a response deadline of October 30, 2026, and falls under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 2 months

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

BARDA is seeking contractors to support the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The selected providers will be responsible for furnishing all necessary personnel, materials, and facilities to produce vaccines, antigens, and adjuvants for pandemic preparedness and public health emergencies. This includes generating and submitting critical analytical, clinical, and manufacturing data to the FDA to ensure rapid regulatory decisions and manufacturing readiness. To be eligible for this award, offerors must have experience producing vaccines against influenza and strains with pandemic potential. Mandatory qualifications include either holding a U.S. influenza vaccine license or demonstrating the development of an influenza vaccine through the submission of a Biologics License Application for seasonal or pandemic vaccines. This solicitation is managed by the Department of Health and Human Services with a response deadline of October 30, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 2 months

Animal Model Development for Phosphine & Cyanide ExposureThis contract involves the development and validation of animal models designed to accurately replicate human exposure to phosphine and cyanide. These models are intended to be used for testing medical countermeasures under the FDA Animal Rule, which provides regulatory pathways for drugs and biologics when human trials are not ethical or feasible. The work falls under the subcontract category and is associated with the Department of Health and Human Services, specifically managed by BARDA (Biomedical Advanced Research and Development Authority) and affiliated offices. The focus of the effort is to create reliable and scientifically robust animal models that can simulate the toxicological and pharmacological effects of phosphine and cyanide exposure in humans. This will facilitate the evaluation and approval of medical treatments aimed at counteracting these toxic agents in emergency or threat scenarios. The contract aligns with NAICS code 541715, which involves research and development in the physical, engineering, and life sciences sectors. The solicitation was posted in April 2026, and although specific details on location and points of contact are not provided, the contract is accessible through official government procurement platforms.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Expanded Biological Sample Analysis (Toxicology & Biomarkers)The contract involves the comprehensive analysis of biological samples, including blood, serum, and urine, to identify toxicological markers, conduct metabolomic profiling, and gather pharmacokinetic data. This work is aimed at assessing the safety and efficacy of medical countermeasures (MCM), supporting efforts to ensure that these interventions meet required safety standards and perform effectively in relevant scenarios. The contract falls under the NAICS code 541620, which relates to environmental consulting services, indicating specialized scientific and analytical work. Awarded by the Department of Health and Human Services through the Biomedical Advanced Research and Development Authority (BARDA), the subcontract focuses on advanced biological sample analysis as part of ongoing health protection initiatives. Although specific solicitation and contact details are not provided, the contract was posted in April 2026 and is intended to bolster toxicological and biomarker research critical to public health preparedness and response efforts. The work is conducted under the oversight of BARDA programs, underscoring its strategic importance in developing therapeutic and diagnostic solutions.

Environmental Consulting Services

POSTED

DEADLINE

In Vivo Imaging and Data Acquisition (Preclinical)This contract involves conducting in vivo preclinical imaging using modalities such as MRI, CT, and PET to study live animal models during nonclinical investigations. The goal is to evaluate physiological responses to various chemical agents and medical countermeasures, supporting the assessment and development of these substances. The contract is issued as a subcontract under the NAICS code 541380 and is managed by the Department of Health and Human Services through its bureaus including BARDA and ASPR. The contract emphasizes data acquisition and analysis in preclinical settings, playing a critical role in advancing medical research and product development aimed at improving public health preparedness and response. The location details and point of contact information were not specified, but the contract was posted on April 22, 2026, reflecting ongoing efforts to support nonclinical study capabilities in biomedical research.

Testing Laboratories and Services

POSTED

DEADLINE

Tissue Collection, Processing, and HistopathologyThis contract involves the collection, preservation, sectioning, and histological analysis of animal tissues following exposure to chemical agents and medical countermeasures (MCMs). The purpose is to support toxicology and efficacy assessments, ensuring thorough examination of tissue responses to these substances. The scope includes detailed processing and microscopic evaluation to provide critical data for understanding the biological effects and safety profiles of the tested agents. Issued by the Department of Health and Human Services under the BARDA-ASPR/DAAPO/BARDA DCMA umbrella, this subcontract falls under the NAICS code 541611, indicating professional, scientific, and technical services. The contract was posted on April 22, 2026, and although specific location details and points of contact are not provided, it is structured to facilitate specialized laboratory analysis essential for public health preparedness and response initiatives.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Nonclinical Animal Dose Escalation Studies (Schedule 1 Chemicals)This contract involves the execution of nonclinical dose escalation studies using highly hazardous chemical agents, such as phosphine and cyanide, in animal models. The primary goal is to evaluate the efficacy of medical countermeasures under the FDA’s Animal Rule, which allows for drug approval based on animal testing when human trials are not ethical or feasible. The work focuses on Schedule 1 chemicals, requiring strict adherence to safety and regulatory standards due to the high-risk nature of the substances involved. The contract is a subcontract under the Department of Health and Human Services, specifically managed by the Biomedical Advanced Research and Development Authority (BARDA) along with associated offices. It falls under the NAICS code 541714, which covers research and development in biotechnology. While specific details about the location of performance and points of contact are not provided, the contract supports the development of critical medical countermeasures aimed at protecting public health from chemical threats.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS